Specifications include, but are not limited to: The selected Offeror shall provide consultation, stakeholder engagement, and analysis services to assist the Board in developing a plan to establish an upper payment limit for high-cost drugs in Oregon. Offeror will prepare for and facilitate a minimum of 24 meetings with stakeholders. The meetings will be used as outreach to gather feedback about the process and utilization of setting upper payment limits. The meetings are expected to be conducted virtually. The meetings may include the following groups: Public Employees Benefits Board Oregon Educators Benefits Board Other state-administered health benefits (Medicaid Managed Care Organization) Health benefit plans (individual, large group, small group), multi-employer welfare plans, association plans Plans governed by ERISA Medicare Part D prescription drug plans Oregon Association of Counties Consumer organizations Hospitals Retail pharmacies 340B covered entities More as identified by Agency; Offeror will use the feedback gathered at the meetings to create detailed documentation that outlines the process and different approaches for setting upper payment limits. Offeror will be expected to document, analyze, model and calculate potential savings by setting upper payment limits and provide these findings in a final report to the Agency.
